Nurosym taVNS for Traumatic Brain Injury

(MINT Trial)

Not yet recruiting at 1 trial location
PT
MM
Overseen ByMichael McGinity, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: The University of Texas Health Science Center at San Antonio
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

MINT is a single-site, prospective, randomized, double-blind, sham-controlled pilot trial evaluating the safety and feasibility of transcutaneous auricular vagus nerve stimulation (taVNS) in patients with moderate to severe traumatic brain injury (GCS 3-12). Participants will be randomized to receive either active taVNS or sham stimulation using the same device. The primary objective is to assess the safety and feasibility of taVNS implementation in the acute TBI setting. Secondary objectives include exploratory measurement of serum inflammatory and neuronal injury biomarkers and assessment of functional outcome using the Extended Glasgow Outcome Scale at hospital discharge.

Who Is on the Research Team?

MM

Michael McGinity, MD

Principal Investigator

The University of Texas Health Science Center at San Antonio

Are You a Good Fit for This Trial?

Inclusion Criteria

Glasgow Coma Scale (GCS) Score 3-12
Expected Intensive Care Unit (ICU) stay > 48 hours
I have had a recent traumatic brain injury within the last 24 hours.
See 1 more

Exclusion Criteria

Pregnant
Penetrating brain injury
Any electrical implanted device
See 8 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1 week

Treatment

Participants receive either active taVNS or sham stimulation twice daily with periodic blood draws

7 days
Daily visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment, including assessment of functional outcome using the Extended Glasgow Outcome Scale at hospital discharge

1 week

What Are the Treatments Tested in This Trial?

Interventions

  • Nurosym (sham)
  • Nurosym taVNS

How Is the Trial Designed?

2

Treatment groups

Experimental Treatment

Placebo Group

Group I: Treatment group taVNSExperimental Treatment1 Intervention
Group II: Control groupPlacebo Group1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

The University of Texas Health Science Center at San Antonio

Lead Sponsor

Trials
486
Recruited
92,500+

Parasym Ltd.

Industry Sponsor

Trials
1
Recruited
80+